An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric Hypoglycemia

Available (expanded access)

Conditions studied: Post-bariatric Hypoglycemia

In brief

The Expanded Access Program will provide access to avexitide for people with post-bariatric hypoglycemia (PBH) following Roux-en-Y gastric bypass (RYGB) who meet the eligibility criteria for this program. The safety of avexitide and patient treatment experience will be monitored during this program.

Key facts

Study ID

NCT07582874

Run by

Amylyx Pharmaceuticals Inc.

Last updated by the study team

2026-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Joslin Diabetes Center — Boston, Massachusetts, United States
• Centricity Research Morehead City Multispecialty — Morehead City, North Carolina, United States
• Southern Endocrinology and Diabetes Associates — Mesquite, Texas, United States
• Diabetes and Glandular Disease Clinic — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.